Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 68Prostatic Neoplasms, Castration-Resistant 6Metastatic Castration-resistant Prostate Cancer 6Neoplasms 4Metastatic Castration Resistant Prostate Cancer 4Urogenital Neoplasms 3Prostate Cancer Metastatic 3Neoplasm Metastasis 3Metastatic Castration-Resistant Prostate Cancer 3Genital Neoplasms, Male 3Breast Neoplasms 3Prostatic Diseases 2Neoplasms by Site 2Genital Diseases, Male 2Carcinoma, Non-Small-Cell Lung 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1NSCLC Harboring NRG1 Fusion 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration-resistant Prostate Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Male Urogenital Diseases 1Hyperaldosteronism 1Colorectal Neoplasms 1Advanced Prostate Cancer 1Advanced Cancer 1Adenocarcinoma 1

Interventions

Goserelin 2enzalutamide 1bicalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Leuprolide 1Gonadotropin-Releasing Hormone 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Advanced Prostate Cancer × Abiraterone Acetate × Clear all
NCT07198633 2026-06-02

A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Recruiting
212 enrolled
Genitourinary

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡